Recent 8-K filings for VYCO

• May 15, 2026, 3:42 PM ET earnings materiality 0.55 positive item 2.02item 9.01

  Vycor Medical Q1 2026 revenue up 5% to $458,540; turns to operating profit of $45,808

  Revenue $458,540 (+5% YoY); Vycor Medical division contributed $440,441.

• March 31, 2026, 7:59 PM ET earnings materiality 0.70 positive item 2.02item 9.01 ◈ Earnings Releases

  Vycor Medical annual revenue up 17% to $1.86M; operating profit swings to positive

  Total revenue $1,863,400 (+17% YoY); Vycor Medical division $1,796,070 (+18%), driven by international growth.

• November 14, 2025, 6:59 PM ET earnings materiality 0.70 positive item 2.02item 9.01

  Vycor Medical Q3 revenue $514K (+31% YoY); posts GAAP operating profit of $32K

  Q3 2025 revenue $513,792, up 31% YoY; Vycor Medical division up 32% to $492K, mostly US growth.

• August 8, 2025, 7:59 PM ET earnings materiality 0.65 positive item 2.02item 9.01

  Vycor Medical Q2 revenue up 22% to $496K; VBAS division drives growth with new international distribution

  Q2 total revenue $496,353 (+22% YoY); Vycor Medical (VBAS) up 24% to $481,788, led by international markets.

• May 15, 2025, 7:59 PM ET earnings materiality 0.60 positive item 2.02item 9.01

  Vycor Medical Q1 revenue up 30% to $436k; operating profit turns positive

  Revenue of $436,378 (+30% YoY); Vycor Medical division revenue $418,520 (+31%).

• April 15, 2025, 7:59 PM ET earnings materiality 0.65 neutral item 2.02item 9.01

  Vycor Medical reports 2024 revenue up 9% to $1.59M; engages Maxim Group for strategic growth

  Revenue $1,589,324 (+9% YoY); Vycor Medical division revenue up 10% to $1,515,744.

Earnings & guidance

Materiality & sentiment trend

Max materiality 0.70 · Median 0.65 · Most common event earnings

5 positive 0 negative 1 neutral

source · VYCO on sec.gov